Global Transcatheter Aortic Valve Implantation (TAVI) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Transcatheter Aortic Valve Implantation (TAVI) Market 2024 by Company, Regions, Type and Application, Forecast to 2030

According to our (Global Info Research) latest study, the global Transcatheter Aortic Valve Implantation (TAVI) market size was valued at USD 4124.6 million in 2023 and is forecast to a readjusted size of USD 5469.9 million by 2030 with a CAGR of 4.1% during review period.

Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.

In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.

East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.

In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.

The Global Info Research report includes an overview of the development of the Transcatheter Aortic Valve Implantation (TAVI) industry chain, the market status of Aortic Stenosis (Transfemoral Approach, Transapical Approach), Aortic Regurgitation (Transfemoral Approach, Transapical Approach), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Transcatheter Aortic Valve Implantation (TAVI).

Regionally, the report analyzes the Transcatheter Aortic Valve Implantation (TAVI) markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Transcatheter Aortic Valve Implantation (TAVI) market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the Transcatheter Aortic Valve Implantation (TAVI) market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Transcatheter Aortic Valve Implantation (TAVI) industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Transfemoral Approach, Transapical Approach).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Transcatheter Aortic Valve Implantation (TAVI) market.

Regional Analysis: The report involves examining the Transcatheter Aortic Valve Implantation (TAVI) market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Transcatheter Aortic Valve Implantation (TAVI) market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Transcatheter Aortic Valve Implantation (TAVI):

Company Analysis: Report covers individual Transcatheter Aortic Valve Implantation (TAVI) players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Transcatheter Aortic Valve Implantation (TAVI) This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Aortic Stenosis, Aortic Regurgitation).

Technology Analysis: Report covers specific technologies relevant to Transcatheter Aortic Valve Implantation (TAVI). It assesses the current state, advancements, and potential future developments in Transcatheter Aortic Valve Implantation (TAVI) areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Transcatheter Aortic Valve Implantation (TAVI) market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation

Transcatheter Aortic Valve Implantation (TAVI) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Transfemoral Approach
Transapical Approach
Others

Market segment by Application
Aortic Stenosis
Aortic Regurgitation
Others

Market segment by players, this report covers
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Transcatheter Aortic Valve Implantation (TAVI) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Transcatheter Aortic Valve Implantation (TAVI), with revenue, gross margin and global market share of Transcatheter Aortic Valve Implantation (TAVI) from 2019 to 2024.

Chapter 3, the Transcatheter Aortic Valve Implantation (TAVI) competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Transcatheter Aortic Valve Implantation (TAVI) market forecast, by regions, type and application, with consumption value, from 2025 to 2030.

Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Aortic Valve Implantation (TAVI).

Chapter 13, to describe Transcatheter Aortic Valve Implantation (TAVI) research findings and conclusion.